206 related articles for article (PubMed ID: 12296588)
21. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.
Muscará MN; Vergnolle N; Lovren F; Triggle CR; Elliott SN; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Apr; 129(7):1423-30. PubMed ID: 10742298
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis.
Lohinai Z; Stachlewitz R; Székely AD; Fehér E; Dézsi L; Szabó C
Life Sci; 2001 Dec; 70(3):279-90. PubMed ID: 12005261
[TBL] [Abstract][Full Text] [Related]
23. A morphometric and histopathologic evaluation of the effects of propolis on alveolar bone loss in experimental periodontitis in rats.
Toker H; Ozan F; Ozer H; Ozdemir H; Eren K; Yeler H
J Periodontol; 2008 Jun; 79(6):1089-94. PubMed ID: 18533788
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
[TBL] [Abstract][Full Text] [Related]
26. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
Bresalier RS
Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
[No Abstract] [Full Text] [Related]
27. The histopathological and morphometric investigation of the effects of systemically administered boric acid on alveolar bone loss in ligature-induced periodontitis in diabetic rats.
Balci Yuce H; Toker H; Goze F
Acta Odontol Scand; 2014 Nov; 72(8):729-36. PubMed ID: 24720865
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis.
Vardar S; Baylas H; Huseyinov A
J Periodontol; 2003 Jan; 74(1):57-63. PubMed ID: 12593597
[TBL] [Abstract][Full Text] [Related]
29. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
30. The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.
Feitosa DS; Marques MR; Casati MZ; Sallum EA; Nociti FH; de Toledo S
J Periodontal Res; 2009 Aug; 44(4):472-8. PubMed ID: 18973522
[TBL] [Abstract][Full Text] [Related]
31. Micro-computerized tomography analysis of alveolar bone loss in ligature- and nicotine-induced experimental periodontitis in rats.
Liu YF; Wu LA; Wang J; Wen LY; Wang XJ
J Periodontal Res; 2010 Dec; 45(6):714-9. PubMed ID: 20572916
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.
Leitão RF; Ribeiro RA; Chaves HV; Rocha FA; Lima V; Brito GA
J Periodontol; 2005 Jun; 76(6):956-63. PubMed ID: 15948691
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
[TBL] [Abstract][Full Text] [Related]
34. Effects of short- and long-term celecoxib on orthodontic tooth movement.
Hauber Gameiro G; Nouer DF; Pereira Neto JS; Siqueira VC; Andrade ED; Duarte Novaes P; Veiga MC
Angle Orthod; 2008 Sep; 78(5):860-5. PubMed ID: 18298225
[TBL] [Abstract][Full Text] [Related]
35. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
36. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
37. Effect of body weight in the pathogenesis of ligature-induced periodontal disease in Wistar rats.
Simch RP; Gaio EJ; Rosing CK
Acta Odontol Scand; 2008 Jun; 66(3):130-4. PubMed ID: 18568470
[TBL] [Abstract][Full Text] [Related]
38. Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats.
Queiroz-Junior CM; Pacheco CM; Maltos KL; Caliari MV; Duarte ID; Francischi JN
J Periodontal Res; 2009 Apr; 44(2):153-60. PubMed ID: 19210344
[TBL] [Abstract][Full Text] [Related]
39. Histological analysis of orthodontic root resorption in rats treated with the cyclooxygenase-2 (COX-2) inhibitor celecoxib.
Gameiro GH; Nouer DF; Pereira-Neto JS; de Araújo Magnani MB; de Andrade ED; Novaes PD; de Arruda Veiga MC
Orthod Craniofac Res; 2008 Aug; 11(3):156-61. PubMed ID: 18713152
[TBL] [Abstract][Full Text] [Related]
40. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats.
Verzeletti GN; Gaio EJ; Rösing CK
Acta Odontol Scand; 2007 Nov; 65(6):348-51. PubMed ID: 18071956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
